IL6 and triple-A syndrome: Consistent with the in vivo results showing that TLR4 signaling mediates IL-6 and MCP-1 production in VSMCs, TLR4 deficiency suppressed IL-6 and MCP-1 levels when the macrophage burden remains low in the early stage of AAA.